Gil, J, de Pedro-Campos, P, Carrato, C, Jardí-Yanes, P, Marques-Pamies, M, Rodríguez-Lloveras, H, Rueda-Pujol, A, Marcos-Ruiz, J, Martinez-Saez, E, Alvarez, CV, Bernabéu, I, Delgado, E, Lamas, C, Picó, A, Webb, SM, Menéndez, E, Martínez-Hernández, R, Sampedro, M, Aulinas, A, Biagetti, B, Marazuela, M, Valassi, E, Jordà, M, Puig-Domingo, M. Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview. Machine Learning And Knowledge Extraction. 2026; 8(1)DOI:10.3390/make8010016. PMID:. IF:(Q/D).

Galbiati, F, Plessow, F, Plummer, L, Campbell, MB, Nazarloo, S, Carter, CS, Davis, JM, Miller, KK, Carroll, RS, Kaiser, UB, Seminara, SB, Aulinas, A, Lawson, EA. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans. JOURNAL OF NEUROENDOCRINOLOGY. 2026; 38(1)DOI:10.1111/jne.70114. PMID:41273106. IF:4.100(Q1/3D).

Melmed, S, di Filippo, L, Fleseriu, M, Mercado, M, Karavitaki, N, Gurnell, M, Salvatori, R, Tsagarakis, S, Losa, M, Maffei, P, Pereira, AM, Geer, EB, Katznelson, L, van der Lely, AJ, Bollerslev, J, Esposito, D, Webb, SM, Zatelli, MC, Valassi, E, Neggers, S, Chanson, P, Ho, KKY, Ioachimescu, AG, Biller, BMK, Samson, SL, Kaiser, UB, Schilbach, K, Luque, RM, Casanueva, FF, Shimon, I, Boguszewski, CL, Biermasz, N, Colao, A, Pirchio, R, Lamberts, SWJ, Kadioglu, P, Buchfelder, M, Frara, S, Chiloiro, S, Petersenn, S, Gadelha, MR, Puig-Domingo, M, Luger, A, Brue, T, Beckers, A, Ferone, D, Clemmons, DR, Greenman, Y, Marazuela, M, Mortini, P, Strasburger, CJ, Giustina, A. Consensus on acromegaly therapeutic outcomes: an update. Nature Reviews Endocrinology. 2025; 21(11)DOI:10.1038/s41574-025-01148-2. PMID:40804505. IF:40.000(Q1/1D).

Martel-Duguech, L, Bascuñana, H, Cuartero, J, Webb, SM, Valassi, E. Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly. Pituitary. 2025; 28(3)DOI:10.1007/s11102-025-01539-8. PMID:40442526. IF:3.400(Q2/4D).